Nir Sassi
Vermogen: 47 094 $ op 31-05-2026
Vermogen: 47 094 $ op 31-05-2026
Nir Sassi worked as Senior Manager at PricewaterhouseCoopers (Israel) from 2002 to 2010.
Served as Chief Financial Officer at Intec Pharma Ltd. from 2016 to 2021.
Served as Chief Financial Officer at Indaptus Therapeutics, Inc. from 2021 to 2023.
Completed undergraduate studies at Ben-Gurion University of the Negev.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-12-2025 | 26.758 ( 0,02% ) | 47 094 $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-04-2026 |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-01-2010 |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau